🔗 Share this article

An underground economy for unlicensed weight-loss medications is propelled by TikTok fitness influencers and vendors on messaging platforms, based on new investigations.

Investigational Drug Gaining Traction Via Social Media

Retatrutide, which remains in clinical trials, is being advertised by social media influencers for its alleged weight-reducing effects. Followers are urged to message these accounts privately for supplier links, while also receiving promotional offers.

Thriving Trade on Messaging Platforms

Separately, a robust market exists on Telegram, where communities with thousands of members share “before and after” photos, administration instructions and assertions of next-day UK delivery. Sellers promote the substance there before redirecting buyers to other platforms for purchases.

Understanding Retatrutide

Retatrutide is an investigational injectable created by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies indicate it could assist patients lose up to 25% of their total weight. Referred to as the “triple G”, the substance is being promoted digitally as the successor to Ozempic.

Healthcare Professionals Voice Worries

However, doctors and chemists have warned that the distribution of what is still an unapproved medication in the United Kingdom is a cause for concern and could lead to individuals injecting products of unknown origin.

Some experts said the demand for retatrutide could be connected to the increasing price of approved slimming products such as Mounjaro.

Legal Status and Implementation

Selling the unapproved drug on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unlicensed medication that must not be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.

Several influencers attempt to sidestep the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and supply can still violate medicines, marketing, and customer laws, risking penalties, prosecution or prison.

Service Response and Content Elimination

According to TikTok, the service has taken down problematic content and banned related hashtags and search suggestions. The company said it was dedicated to maintaining the service safe and investing in strengthening compliance measures.

Digital Trading Operations

Research also discovered communities with up to nine thousand participants selling retatrutide using the platform's built-in discovery tool, which functions like a public directory. Entering “retatrutide” instantly displays channels with numerous of members, filled with photos of slimming results, glowing testimonials and step-by-step guides for mixing or injecting at residence.

Within moments of joining one group, a vendor shared contact information, where most transactions occur. The vendor sent an instruction manual and promised delivery within two days. When questioned whether the substance was genuine, one vendor said: “You can’t be sure.” Another shared a image of a alleged testing documentation. Not one asked about body mass, health issues or past usage.

Product Information and Costs

Within these communities, posts display dark colored parcels with postal service stickers, claiming to contain fresh supplies. One message read: “It took eight of us to load them this morning.”

Customers can select between powder vials, mixed at residence with sterile water, or ready-to-use injectors typically priced at 160 pounds for 20mg. When asked how long a injector should last, vendors give conflicting responses ranging from a few weeks to “depends on your body”.

Service Oversight and Security Measures

A representative for the messaging service said it regularly moderated harmful content on its platform including material that promoted the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“Individuals are administering substances they can’t verify. Although the science behind retatrutide is sound, these online versions may not contain what they advertise,” stated a pharmacy expert, the director of pharmacy at a pharmacy service.

A medical professional of Asda Online Doctor connected the increase in interest to recent price rises for authorized weight-loss drugs such as Mounjaro. “With costs rising, individuals are using online platforms. But counterfeit treatments are highly dangerous. You can’t be certain what’s contained or whether the environment they were made in was sterile,” she said.

Her staff has previously seen individuals injured by self-injection from unverified suppliers. “We recognize the frustration, but purchasing from Telegram or WhatsApp is taking chances with your health,” said Wyllie. “These materials could be contaminated or incorrectly dosed.”

Manufacturer Position

A spokesperson from the pharmaceutical company stated retatrutide was in phase 3 clinical trials and had not been reviewed or authorized by any regulatory agency globally. “Consequently at this point no one can sell [it] for human use,” they explained, adding that any product “falsely representing itself as a company experimental substance not yet approved … may expose users to potentially significant health risks”.